Avestar Capital’s GoodRx Holdings GDRX Stock Holding History

Avestar Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,360	Closed	-$220K	–	460
2021 Q3	$220K	Sell	5,360 -600	-10%	-$21.8K	0.03%	415
2021 Q2	$215K	Sell	5,960 -1,000	-14%	-$36.9K	0.03%	411
2021 Q1	$279K	Buy	+6,960	New	+$313K	0.06%	258
2020 Q4	–	Sell	-4,760	Closed	-$236K	–	273
2020 Q3	$236K	Buy	+4,760	New	+$252K	0.08%	192

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Avestar Capital's GDRX Position: Q4 2021 in Review

Avestar Capital sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 5,360 shares — an estimated $220K sold.

Avestar Capital first reported a position in GDRX in Q3 2020 and held it in 4 quarters. The position peaked at $279K in Q1 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

Avestar Capital reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
Avestar Capital sold 5,360 GoodRx Holdings shares in Q4 2021, an estimated $220K.
Avestar Capital first reported a position in GoodRx Holdings in Q3 2020 and held it in 4 quarters.
Avestar Capital's GoodRx Holdings position peaked at $279K in Q1 2021.
216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on Avestar Capital's 13F filing for Q4 2021, filed 1 Feb 2022.